Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itaru Hashimoto

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[The Case of HER2 Positive Advanced Gastric Cancer with Para-Aorta Lymph Node Recurrence Responding to Capecitabine plus CDDP plus Trastuzumab Chemotherapy]Itaru Hashimoto, Hitoshi Murakami, Sayaka Arisaka, et al.
In Vivo (Athens, Greece)|September 3, 2020
The Short- and Long-term Outcomes of Gastrectomy in Elderly Patients With Gastric CancerKeisuke Komori, Kazuki Kano, Toru Aoyama, et al.
Anticancer Research|July 27, 2022
Clinical Significance of <i>EREG</i> Gene Expression in Gastric Cancer Tissue After Curative SurgeryHideaki Suematsu, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Langenbeck'S Archives of Surgery|October 21, 2024
Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Anticancer Research|May 31, 2024
Comparison of Survival Between ypStage and pStage in Gastric CancerKeisuke Komori, Takanobu Yamada, Shuji Ando, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Global Immune-Nutrition-Information Index Is Independent Prognostic Factor for Gastric Cancer Patients Who Received Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|February 2, 2024
Clinical Significance of Tryptophanyl-tRNA Synthetase 1 Gene Expression in Patients With Locally Advanced Gastric CancerTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
In Vivo (Athens, Greece)|April 28, 2022
Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Daisuke Machida, et al.
In Vivo (Athens, Greece)|March 1, 2020
Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal CancerToru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
In Vivo (Athens, Greece)|June 27, 2025
The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After EsophagectomyToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[The Case of HER2 Positive Advanced Gastric Cancer with Para-Aorta Lymph Node Recurrence Responding to Capecitabine plus CDDP plus Trastuzumab Chemotherapy]Itaru Hashimoto, Hitoshi Murakami, Sayaka Arisaka, et al.
In Vivo (Athens, Greece)|September 3, 2020
The Short- and Long-term Outcomes of Gastrectomy in Elderly Patients With Gastric CancerKeisuke Komori, Kazuki Kano, Toru Aoyama, et al.
Anticancer Research|July 27, 2022
Clinical Significance of <i>EREG</i> Gene Expression in Gastric Cancer Tissue After Curative SurgeryHideaki Suematsu, Itaru Hashimoto, Yukihiko Hiroshima, et al.
Langenbeck'S Archives of Surgery|October 21, 2024
Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancerShinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, et al.
Anticancer Research|May 31, 2024
Comparison of Survival Between ypStage and pStage in Gastric CancerKeisuke Komori, Takanobu Yamada, Shuji Ando, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
Global Immune-Nutrition-Information Index Is Independent Prognostic Factor for Gastric Cancer Patients Who Received Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|February 2, 2024
Clinical Significance of Tryptophanyl-tRNA Synthetase 1 Gene Expression in Patients With Locally Advanced Gastric CancerTakashi Oshima, Itaru Hashimoto, Yukihiko Hiroshima, et al.
In Vivo (Athens, Greece)|April 28, 2022
Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Mihwa Ju, Daisuke Machida, et al.
In Vivo (Athens, Greece)|March 1, 2020
Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal CancerToru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
In Vivo (Athens, Greece)|June 27, 2025
The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After EsophagectomyToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Pageof 13